AVEO Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AVEO and buy or sell other stocks, ETFs, and their options commission-free!About AVEO
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353.
CEOMichael P. Bailey, MBA
CEOMichael P. Bailey, MBA
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2001
Founded2001
Employees—
Employees—
AVEO Key Statistics
Market cap521.45M
Market cap521.45M
Price-Earnings ratio-17.81
Price-Earnings ratio-17.81
Dividend yield—
Dividend yield—
Average volume545.54K
Average volume545.54K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$15.00
52 Week high$15.00
52 Week low$3.06
52 Week low$3.06
Stock Snapshot
The current AVEO Pharmaceuticals(AVEO) stock price is $15.00, with a market capitalization of 521.45M. The stock trades at a price-to-earnings (P/E) ratio of -17.81.
AVEO Pharmaceuticals(AVEO) stock opened on 2025-11-23 at —. The price climbed to — and dipped to —.
The AVEO Pharmaceuticals(AVEO)'s current trading volume is 0, compared to an average daily volume of 545.54K.
In the last year, AVEO Pharmaceuticals(AVEO) shares hit a 52-week high of $15.00 and a 52-week low of $3.06.
In the last year, AVEO Pharmaceuticals(AVEO) shares hit a 52-week high of $15.00 and a 52-week low of $3.06.
People also own
Based on the portfolios of people who own AVEO. This list is generated using Robinhood data, and it’s not a recommendation.